Overview

Exploring Vancomycin Disposition in Neonates

Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Vancomycin is already used for decades in neonates. However, there are remaining questions concerning vancomycin disposition in this population. The purpose of this study is first of all to perform a paired analysis of serum vancomycin concentrations using an immunoassay versus a reference liquid chromatography-tandem mass spectrometry method. Secondly, we aim to determine vancomycin protein binding and its covariates in neonates.
Phase:
Phase 4
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Treatments:
Vancomycin